202 related articles for article (PubMed ID: 33464660)
1. Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo-controlled trial.
Mongeau-Pérusse V; Brissette S; Bruneau J; Conrod P; Dubreucq S; Gazil G; Stip E; Jutras-Aswad D
Addiction; 2021 Sep; 116(9):2431-2442. PubMed ID: 33464660
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trial.
Rizkallah E; Mongeau-Pérusse V; Lamanuzzi L; Castenada-Ouellet S; Stip E; Juteau LC; Brissette S; Bruneau J; Dubreucq S; Jutras-Aswad D
Pharmacol Biochem Behav; 2022 May; 216():173376. PubMed ID: 35367279
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.
Hurd YL; Spriggs S; Alishayev J; Winkel G; Gurgov K; Kudrich C; Oprescu AM; Salsitz E
Am J Psychiatry; 2019 Nov; 176(11):911-922. PubMed ID: 31109198
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol Effect on Anxiety Symptoms and Stress Response in Individuals With Cocaine Use Disorder: Exploratory Results From a Randomized Controlled Trial.
Mongeau-Pérusse V; Rizkallah E; Morissette F; Brissette S; Bruneau J; Dubreucq S; Gazil G; Trépanier A; Jutras-Aswad D
J Addict Med; 2022 Sep-Oct 01; 16(5):521-526. PubMed ID: 35135986
[TBL] [Abstract][Full Text] [Related]
5. Absence of Evidence for Sustained Effects of Daily Cannabidiol Administration on Anandamide Plasma Concentration in Individuals with Cocaine Use Disorder: Exploratory Findings from a Randomized Controlled Trial.
Hebert FO; Mongeau-Pérusse V; Rizkallah E; Mahroug A; Bakouni H; Morissette F; Brissette S; Bruneau J; Dubreucq S; Jutras-Aswad D
Cannabis Cannabinoid Res; 2024 May; ():. PubMed ID: 38770686
[No Abstract] [Full Text] [Related]
6. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.
Bhardwaj AK; Mills L; Doyle M; Sahid A; Montebello M; Monds L; Arunogiri S; Haber P; Lorenzetti V; Lubman DI; Malouf P; Harrod ME; Dunlop A; Freeman T; Lintzeris N
BMC Psychiatry; 2024 Mar; 24(1):175. PubMed ID: 38433233
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study.
Meneses-Gaya C; Crippa JA; Hallak JE; Miguel AQ; Laranjeira R; Bressan RA; Zuardi AW; Lacerda AL
Braz J Psychiatry; 2021; 43(5):467-476. PubMed ID: 33146345
[TBL] [Abstract][Full Text] [Related]
8. Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial.
Morissette F; Mongeau-Pérusse V; Rizkallah E; Thébault P; Lepage S; Brissette S; Bruneau J; Dubreucq S; Stip E; Cailhier JF; Jutras-Aswad D
Neuropsychopharmacology; 2021 Nov; 46(12):2101-2111. PubMed ID: 34331010
[TBL] [Abstract][Full Text] [Related]
9. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study.
Suzuki J; Martin B; Prostko S; Chai PR; Weiss RD
Integr Med Rep; 2022 Aug; 1(1):157-163. PubMed ID: 36105269
[TBL] [Abstract][Full Text] [Related]
11. Acute impact of self-guided mental imagery on craving in cocaine use disorder: a mixed-methods analysis of a randomized controlled trial.
Lowry N; Marsden J; Clydesdale B; Eastwood B; Havelka EM; Goetz C
Addiction; 2021 Sep; 116(9):2418-2430. PubMed ID: 33405313
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme.
Hindocha C; Freeman TP; Schafer G; Gardner C; Bloomfield MAP; Bramon E; Morgan CJA; Curran HV
Addict Biol; 2020 May; 25(3):e12762. PubMed ID: 31013550
[TBL] [Abstract][Full Text] [Related]
13. Double-blind evaluation of homeopathy on cocaine craving: a randomized controlled pilot study.
Adler UC; Acorinte AC; Calzavara FO; da Silva AA; de Toledo Cesar A; Adler MS; Martinez EZ; Galduróz JCF
J Integr Med; 2018 May; 16(3):178-184. PubMed ID: 29625852
[TBL] [Abstract][Full Text] [Related]
14. Impact of cannabidiol on reward- and stress-related neurocognitive processes among individuals with opioid use disorder: A pilot, double-blind, placebo-controlled, randomized cross-over trial.
Suzuki J; Prostko S; Szpak V; Chai PR; Spagnolo PA; Tenenbaum RE; Ahmed S; Weiss RD
Front Psychiatry; 2023; 14():1155984. PubMed ID: 37065899
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic: A Randomized Clinical Trial.
Crippa JAS; Zuardi AW; Guimarães FS; Campos AC; de Lima Osório F; Loureiro SR; Dos Santos RG; Souza JDS; Ushirohira JM; Pacheco JC; Ferreira RR; Mancini Costa KC; Scomparin DS; Scarante FF; Pires-Dos-Santos I; Mechoulam R; Kapczinski F; Fonseca BAL; Esposito DLA; Pereira-Lima K; Sen S; Andraus MH; Hallak JEC;
JAMA Netw Open; 2021 Aug; 4(8):e2120603. PubMed ID: 34387679
[TBL] [Abstract][Full Text] [Related]
16. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Rog DJ; Nurmikko TJ; Young CA
Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial.
van der Flier FE; Kwee CMB; Cath DC; Batelaan NM; Groenink L; Duits P; van der Veen DC; van Balkom AJLM; Baas JMP
BMC Psychiatry; 2019 Feb; 19(1):69. PubMed ID: 30760241
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal.
Hindocha C; Freeman TP; Grabski M; Stroud JB; Crudgington H; Davies AC; Das RK; Lawn W; Morgan CJA; Curran HV
Addiction; 2018 May; 113(9):1696-705. PubMed ID: 29714034
[TBL] [Abstract][Full Text] [Related]
19. Multi-session electrical neuromodulation effects on craving, relapse and cognitive functions in cocaine use disorder: A randomized, sham-controlled tDCS study.
Verveer I; van der Veen FM; Shahbabaie A; Remmerswaal D; Franken IHA
Drug Alcohol Depend; 2020 Dec; 217():108429. PubMed ID: 33250383
[TBL] [Abstract][Full Text] [Related]
20. Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.
Gonzalez-Cuevas G; Martin-Fardon R; Kerr TM; Stouffer DG; Parsons LH; Hammell DC; Banks SL; Stinchcomb AL; Weiss F
Neuropsychopharmacology; 2018 Sep; 43(10):2036-2045. PubMed ID: 29686308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
